CANbridge Pharmaceuticals Inc. (HKG:1228)
Hong Kong
· Delayed Price · Currency is HKD 0.1360
+0.0030 (2.26%)
May 30, 2025, 3:59 PM HKT
CANbridge Pharmaceuticals Market Cap
CANbridge Pharmaceuticals has a market cap or net worth of 57.74 million as of May 30, 2025. Its market cap has decreased by -69.46% in one year.
Market Cap
57.74M
Enterprise Value
191.05M
Revenue
90.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since December 10, 2021, CANbridge Pharmaceuticals's market cap has decreased from 3.78B to 57.74M, a decrease of -98.47%. That is a compound annual growth rate of -70.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 57.74M | 2.19% |
| Dec 31, 2024 | 56.50M | -86.56% |
| Dec 29, 2023 | 420.31M | -59.56% |
| Dec 30, 2022 | 1.04B | -72.41% |
| Dec 31, 2021 | 3.77B | -0.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 229.25B |
| Hansoh Pharmaceutical Group Company | 153.70B |
| JD Health International | 128.48B |
| Innovent Biologics | 102.19B |
| WuXi Biologics | 101.51B |
| CSPC Pharmaceutical Group | 92.57B |
| Sino Biopharmaceutical | 79.63B |
| Akeso | 75.22B |